Considering that chronic intermittent hypoxia, a main feature of OSA, suppresses FSTL1 expression, this suggests a potential protective role for FSTL1 in OSA patients by regulating inflammation and oxidative stress; however, this role has not been studied. This evidence concerns the gene FSTL1 and obstructive sleep apnea syndrome.